ArTS Archivio della ricerca di Trieste

PORCARI, ALDOSTEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.587
AS - Asia 5.655
EU - Europa 5.143
SA - Sud America 766
Continente sconosciuto - Info sul continente non disponibili 438
AF - Africa 141
OC - Oceania 20
Totale 18.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.330
IT - Italia 2.413
SG - Singapore 2.005
CN - Cina 1.282
BR - Brasile 596
HK - Hong Kong 539
VN - Vietnam 513
DE - Germania 448
KR - Corea 388
BD - Bangladesh 339
FR - Francia 325
NL - Olanda 271
FI - Finlandia 267
GB - Regno Unito 262
SE - Svezia 257
PL - Polonia 177
RU - Federazione Russa 177
IN - India 141
CA - Canada 113
CH - Svizzera 97
JP - Giappone 86
IE - Irlanda 71
AT - Austria 68
BG - Bulgaria 67
TR - Turchia 66
MX - Messico 61
AR - Argentina 60
ES - Italia 47
MA - Marocco 45
ID - Indonesia 39
IQ - Iraq 32
UA - Ucraina 31
SA - Arabia Saudita 28
CO - Colombia 27
ZA - Sudafrica 25
CZ - Repubblica Ceca 24
BE - Belgio 23
EG - Egitto 21
EC - Ecuador 19
VE - Venezuela 19
PK - Pakistan 18
CL - Cile 17
IR - Iran 16
AU - Australia 15
RO - Romania 14
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
GR - Grecia 13
PE - Perù 13
CR - Costa Rica 11
IL - Israele 11
JO - Giordania 11
LT - Lituania 11
MY - Malesia 11
PH - Filippine 11
JM - Giamaica 10
TH - Thailandia 10
UZ - Uzbekistan 10
DZ - Algeria 9
GE - Georgia 9
NI - Nicaragua 9
NO - Norvegia 9
OM - Oman 9
PT - Portogallo 9
BY - Bielorussia 8
KE - Kenya 8
PA - Panama 8
ET - Etiopia 7
HU - Ungheria 7
KZ - Kazakistan 7
SI - Slovenia 7
SK - Slovacchia (Repubblica Slovacca) 7
SV - El Salvador 6
BO - Bolivia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
SN - Senegal 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AL - Albania 4
AO - Angola 4
AZ - Azerbaigian 4
HN - Honduras 4
HR - Croazia 4
NP - Nepal 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
CU - Cuba 3
GA - Gabon 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LV - Lettonia 3
MM - Myanmar 3
MU - Mauritius 3
PR - Porto Rico 3
Totale 18.254
Salva come PNG Salva come JPEG
Città #
Singapore 1.114
Ashburn 991
San Jose 675
Hong Kong 520
Council Bluffs 498
Hefei 496
Seoul 383
Chandler 363
Trieste 293
Milan 250
Beijing 230
Helsinki 205
Boardman 203
Columbus 191
Los Angeles 177
Dallas 171
Ho Chi Minh City 165
Munich 163
Chicago 161
Rome 145
Fairfield 143
Santa Clara 136
New York 123
Hanoi 116
Lauterbourg 110
London 102
Zgierz 102
Seattle 86
Houston 80
Moscow 74
Naples 73
Frankfurt am Main 72
Bern 71
Dublin 71
Wilmington 70
Woodbridge 67
Buffalo 66
The Dalles 65
São Paulo 64
Sofia 63
Phoenix 60
Princeton 59
Cambridge 54
Warsaw 52
Turin 47
Nuremberg 46
Vienna 43
Florence 42
Tokyo 40
Montreal 37
Lappeenranta 36
Orem 35
Amsterdam 32
Redondo Beach 32
Atlanta 31
Washington 30
Casablanca 29
Da Nang 29
Shanghai 29
Venice 29
Ann Arbor 28
Brooklyn 28
Denver 28
Paris 28
Toronto 28
Chennai 26
Udine 26
Jacksonville 25
Bologna 24
Palermo 24
Verona 24
Mumbai 23
Memphis 22
Bari 21
Düsseldorf 21
Genoa 20
Istanbul 20
Parma 20
Turku 20
Boydton 19
Padova 19
Belo Horizonte 18
Stockholm 18
Venezia 18
Boston 17
Izmir 17
North Bergen 17
Philadelphia 17
Brasília 16
Brussels 15
Charlotte 15
Haiphong 15
Karlsruhe 15
Roubaix 15
Salt Lake City 15
Catania 14
Manchester 14
Mexico City 14
San Francisco 14
Barnet 13
Totale 10.731
Salva come PNG Salva come JPEG
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 577
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 418
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 380
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 322
Cardiac amyloidosis: a changing epidemiology with open challenges 295
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 288
Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with Selumetinib 279
Clinical validation of a coronary surgery technique that minimizes aortic manipulation 272
Terapia di modulazione della contrattilità cardiaca: basi molecolari e razionale per l’impiego in modelli di insufficienza cardiaca sistolica e diastolica 272
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 264
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle 255
Cardiovascular aging: the unveiled enigma from bench to bedside 250
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 248
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 233
The fate of patients having deep sternal infection after bilateral internal thoracic artery grafting in the negative pressure wound therapy era 213
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 210
Cardiac magnetic resonance abnormalities in patients with acute myocarditis proven by septal endomyocardial biopsy 209
Clinical application of cardiac scintigraphy with bone tracers: controversies and pitfalls in cardiac amyloidosis 206
Acute inflammatory cardiomyopathy: apparent neutral prognostic impact of immunosuppressive therapy 206
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 203
Miocarditi, pericarditi e vaccino a mRNA contro il COVID-19. Expert opinion della Società Italiana di Cardiologia 201
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques 197
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis 195
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies 194
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 189
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 188
Radiologia cardiovascolare. 70 anni di immagini dall’“Archivio Camerini” ai giorni nostri 180
Myocarditis: Which Role for Genetics? 180
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 179
Diagnosi e cura dell’amiloidosi cardiaca in Italia: risultati della survey della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 178
Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy 177
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 175
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones 174
Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias 174
The (ultra) sound of a burning heart: A matter of speckles 173
Grey zones in the supportive treatments of cardiac amyloidosis 171
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 170
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation 170
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 166
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 163
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience 163
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization 162
Validation and Performance Comparison of Two Scoring Systems Created Specifically to Predict the Risk of Deep Sternal Wound Infection after Bilateral Internal Thoracic Artery Grafting 159
Clinical Use of Biomarkers in Cardiac Amyloidosis 158
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors 157
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 156
Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery 153
Cardiac amyloidosis: do not forget to look for it 152
Che cos’è l’Amiloidosi? 150
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death 150
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination 149
Re-Definition of the Epidemiology of Cardiac Amyloidosis 148
The Arrhythmic Phenotype in Cardiomyopathy 145
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 144
Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure 142
Transthyretin cardiac amyloidosis 137
Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca 137
Lung damage in SARS-CoV-2 patients: An autopsy study in the era of vaccination 136
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance 134
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 130
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 127
Restrictive cardiomyopathy: definition and diagnosis 122
Trends in age and sex-specific dilated cardiomyopathy mortality in Italy, 2005-2017 121
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 119
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis 118
Cardiac Amyloidosis 118
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy 118
Editorial for the article: Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy 117
Myocardial perfusion in cardiac amyloidosis 116
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy 115
Dieci possibili linee future di ricerca e innovazione nell’amiloidosi cardiaca 115
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis 113
Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy 113
Update 2022 dell’Expert Opinion della Società Italiana di Cardiologia su miocarditi, pericarditi e vaccini contro il COVID-19 112
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years 110
Atrial electro-functional predictors of incident atrial fibrillation in cardiac amyloidosis 109
Standardizing the role of endomyocardial biopsy in current clinical practice worldwide 108
Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis 108
One-Year Risk of myocarditis after COVID-19 infection: a systematic review and meta-analysis 107
Cardiac amyloidosis: when to suspect and how to confirm 106
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 106
Lights and Shadows of Clinical Applications of Cardiac Scintigraphy with Bone Tracers in Suspected Amyloidosis 105
Precision medicine in heart failure no longer a visual theory but a realistic opportunity 104
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis 103
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 103
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 103
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery 101
Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis 100
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 100
Management of hypertrophic cardiomyopathy 99
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 98
Tracking Treatment Response in Cardiac Light-Chain Amyloidosis with Native T1 Mapping 98
Patologie acute del pericardio 95
Expert consensus document on artificial intelligence of the Italian Society of Cardiology 95
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis 94
Conventional heart failure therapy in cardiac ATTR amyloidosis 93
Comparison of 99mTc-DPD Scintigraphy, CMR Imaging, and Echocardiography in Patients With V30M-Associated Hereditary Transthyretin Amyloidosis 92
Final farewell to Claudio Rapezzi: observation, deduction and knowledge in medicine 92
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 91
Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici 89
Totale 16.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022475 0 0 47 28 31 42 34 31 67 37 63 95
2022/20231.357 72 161 152 192 106 188 35 122 159 35 90 45
2023/20241.844 164 92 97 146 138 145 265 235 44 98 213 207
2024/20253.867 136 178 381 303 330 273 286 244 403 555 329 449
2025/20269.087 699 619 712 759 620 754 1.137 375 1.060 1.093 720 539
2026/20271.243 427 559 257 0 0 0 0 0 0 0 0 0
Totale 18.750